Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netakimab in Moderate to Severe Plaque Psoriasis (PLANETA)
NCT03390101Phase 3Completed
- Sponsor
- BIOCAD
- Start
- Dec 2017
- Primary completion
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of netakimab in plaque psoriasis, sponsored by BIOCAD. Started Dec 2017; status: completed.
02
Drugs
netakimab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03390101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03390101.